The Texas Alzheimer’s Research and Care Consortium (TARCC) is a collaboration between ten of the state’s leading medical research institutions, working to improve early diagnosis, treatment, and prevention of Alzheimer’s disease.
1 in 9 people age 65+ has Alzheimer's disease.
About 490,000 Texans are projected to have Alzheimer's by 2025.
Every 66 seconds, someone in the United States develops Alzheimer’s.
TARCC Research Updates
TARCC investigators have been involved in a number of new, important research studies. Recently published research is wide ranging, spanning the gamut from clinical trials to new cognitive diagnostics; blood-based biomarkers in Mexican-Americans; identification of additional risk genes; and validation of biomarker algorithms in AD patients and AD animal models.
Read TARCC's Latest Facebook Posts:
Developed with the TARCC cohort, the Southwestern Assessment of Processing Speed (SWAPS) is a brief, free, and easily administered tool to be used in clinical and research settings for the detection of cognitive impairment and efficient assessment of processing speed.
Please join us at the
TARCC Scientific Symposium: Advances in Alzheimer's Disease Science, Research, and Care
January 27, 2022
UT Austin Etter-Harbin Alumni Center// 2110 San Jacinto Blvd// Austin, TX
In-person with virtual options